Yazar "Alsharif, Yahia H." seçeneğine göre listele
Listeleniyor 1 - 3 / 3
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Application of machine intelligence technology in the detection of vaccines and medicines for SARS-CoV-2(VERDUCI PUBLISHER, VIA GREGORIO VII, ROME 186-00165, ITALY, 2020) Alsharif, Mohammed H.; Alsharif, Yahia H.; Albreem, Mahmoud A. M.; Jahid, Abu; Solyman, Ahmad Amin Ahmad; Yahya, Khalid O. Moh.; Alomari, Osama Ahmad; Hossain, Md. SanwarResearchers have found many similarities between the 2003 severe acute respiratory syndrome (SARS) virus and SARSCoV-19 through existing data that reveal the SARS’s cause. Artificial intelligence (AI) learning models can be created to predict drug structures that can be used to treat COVID-19. Despite the effectively demonstrated repurposed drugs, more repurposed drugs should be recognized. Furthermore, technological advancements have been helpful in the battle against COVID-19. Machine intelligence technology can support this procedure by rapidly determining adequate and effective drugs against COVID-19 and by overcoming any barrier between a large number of repurposed drugs, laboratory/clinical testing, and final drug authorization. This paper reviews the proposed vaccines and medicines for SARSCoV-2 and the current application of AI in drug repurposing for COVID-19 treatment.Öğe Artificial intelligence technology for diagnosing COVID-19 cases: a review of substantial issues(VERDUCI PUBLISHER, VIA GREGORIO VII, ROME 186-00165, ITALY, 2020) Alsharif, Mohammed H.; Alsharif, Yahia H.; Chaudhry, Shehzad Ashraf; Albreem, Mahmoud A. M.; Jahid, Abu; Hwang, EenjunToday, the world suffers from the rapid spread of COVID-19, which has claimed thousands of lives. Unfortunately, its treatment is yet to be developed. Nevertheless, this phenomenon can be decelerated by diagnosing and quarantining patients with COVID-19 at early stages, thereby saving numerous lives. In this study, the early diagnosis of this disease through artificial intelligence (AI) technology is explored. AI is a revolutionizing technology that drives new research opportunities in various fields. Although this study does not provide a final solution, it highlights the most promising lines of research on AI technology for the diagnosis of COVID-19. The major contribution of this work is a discussion on the following substantial issues of AI technology for preventing the severe effects of COVID-19: (1) rapid diagnosis and detection, (2) outbreak and prediction of virus spread, and (3) potential treatments. This study profoundly investigates these controversial research topics to achieve a precise, concrete, and concise conclusion. Thus, this study provides significant recommendations on future research directions related to COVID-19.Öğe Deep learning applications to combat the dissemination of COVID-19 disease: a review(VERDUCI PUBLISHER, VIA GREGORIO VII, ROME 186-00165, ITALY, 2020) Alsharif, Mohammed H.; Alsharif, Yahia H.; Yahya, Khalid O. Moh.; Alomari, Osama Ahmad; Albreem, Mahmoud A. M.; Jahid, AbuRecent Coronavirus (COVID-19) is one of the respiratory diseases, and it is known as fast infectious ability. This dissemination can be decelerated by diagnosing and quarantining patients with COVID-19 at early stages, thereby saving numerous lives. Reverse transcription-polymerase chain reaction (RTPCR) is known as one of the primary diagnostic tools. However, RT-PCR tests are costly and time-consuming; it also requires specific materials, equipment, and instruments. Moreover, most countries are suffering from a lack of testing kits because of limitations on budget and techniques. Thus, this standard method is not suitable to meet the requirements of fast detection and tracking during the COVID-19 pandemic, which motived to employ deep learning (DL)/ convolutional neural networks (CNNs) technology with X-ray and CT scans for efficient analysis and diagnostic. This study provides insight about the literature that discussed the deep learning technology and its various techniques that are recently developed to combat the dissemination of COVID-19 disease.